Systemic gemcitabine combined with intra-arterial low-dose cisplatin and 5-fluorouracil for advanced hepatocellular carcinoma: Seven cases

doi:10.3748/wjg.14.2602

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 16

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2793)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-2) series.

Item

Count

PDF

284

HTML

2082

Figures (1-2)

195

Tables (1-2)

232

Sum=2793

Apr 28, 2008 (publication date) through Oct 2, 2024

Times Cited of This Article

Times Cited (1)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Gastroenterol. Apr 28, 2008; 14(16): 2602-2608
Published online Apr 28, 2008. doi: 10.3748/wjg.14.2602

Full Size Figure Download Figure

Figure 2 After three courses of GEMFP, CT scanning showed marked regression of the primary tumor (55 mm) with demonstrable portal blood flow (arrow) and the disappearance of hepatic venous tumor thrombus in the inferior vena cava.

Citation: Uka K, Aikata H, Takaki S, Kawaoka T, Saneto H, Miki D, Takahashi S, Toyota N, Ito K, Chayama K. Systemic gemcitabine combined with intra-arterial low-dose cisplatin and 5-fluorouracil for advanced hepatocellular carcinoma: Seven cases. World J Gastroenterol 2008; 14(16): 2602-2608
URL: https://www.wjgnet.com/1007-9327/full/v14/i16/2602.htm
DOI: https://dx.doi.org/10.3748/wjg.14.2602